In January 2016, NCOH’s own bilingual Twitter account, @ncohnl, was registered. With investigators in the field of one health as a primary target group, via this Twitter account relevant developments in the context of one health are highlighted.
By the end of 2018 the account had approximately 675 followers and close to 500 tweets had been sent out. Particularly successful (based on the number of impressions, defined as the number of times that users saw a tweet) in 2018 were the twitter campaigns related to NCOH-sponsored/organized meetings. To mention a few: (1) a series of 15 tweets related to the NCOH Annual Scientific Meeting (May 30) with over 35.000 impressions, (2) a series of 10 tweets on the NCOH symposium on bacteriophage therapy (Feb 22) with over 16.000 impressions, and (3) a series of 6 tweets at the NCOH Science Café of Nov 11 with over 8.000 impressions.
The Top-5 of most successful individual tweets during 2018 (based on impressions):
Rory de Vries (born 1982) is receiving the premium for his research on the human body’s defences against respiratory viral infections, and for his ability to communicate his knowledge of virology and infectious diseases to a wide audience. Rory de Vries is a post-doctoral researcher at Erasmus MC in Rotterdam.
On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.
Contamination with resistant bacteria in patients admitted to Dutch hospitals does not result in higher mortality than contamination by non-resistant bacteria. Although the problem of antibiotic resistance in the Netherlands currently seems manageable, it is important to remain vigilant in view of the ever-changing epidemiology of resistant bacteria, according to Wouter Rottier, who was awarded...
Radboudumc has combined its research into controlled human infection models to create a new program: the Radboudumc Controlled Human Infection Models (RCHIM). By studying the interaction between pathogens and humans under controlled conditions, researchers can improve their understanding of the underlying disease mechanisms. This understanding contributes to a more targeted development of medicines and vaccines...